Literature DB >> 11276392

Syndrome X following renal transplantation.

S B Nicholas1.   

Abstract

The cardiovascular risk factors that accompany postrenal transplantation include an atherogenic lipid profile, hypertension, new-onset diabetes mellitus, and a chronic prothrombotic state. This picture describes the dysmetabolic syndrome or syndrome X, which can significantly aggravate not only the risk of cardiovascular disease and death in this population, but also the progression of allograft dysfunction. The recognition and aggressive management of the dysmetabolic syndrome in postrenal allograft recipients may have a favorable impact on the incidence of cardiovascular morbidity and mortality in these patients and prolong allograft function.

Entities:  

Mesh:

Year:  2001        PMID: 11276392     DOI: 10.1007/s11906-001-0023-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  16 in total

Review 1.  Effect of HMG-CoA reductase inhibitors on chronic allograft rejection.

Authors:  S Katznelson
Journal:  Kidney Int Suppl       Date:  1999-07       Impact factor: 10.545

2.  Prospective study of lipid disorders in FK506-versus cyclosporine-treated renal transplant patients.

Authors:  C G Vela; J P Cristol; B Descomps; G Mourad
Journal:  Transplant Proc       Date:  2000-03       Impact factor: 1.066

3.  Plasma lipids following renal transplantation.

Authors:  P Ghosh; D B Evans; S A Tomlinson; R Y Calne
Journal:  Transplantation       Date:  1973-05       Impact factor: 4.939

4.  Incidence and long-term cost of steroid-related side effects after renal transplantation.

Authors:  D L Veenstra; J H Best; J Hornberger; S D Sullivan; D E Hricik
Journal:  Am J Kidney Dis       Date:  1999-05       Impact factor: 8.860

5.  Factors determining the prevalence of hypertension after renal transplantation.

Authors:  F T Huysmans; A J Hoitsma; R A Koene
Journal:  Nephrol Dial Transplant       Date:  1987       Impact factor: 5.992

6.  Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients.

Authors:  Z A Massy; B Chadefaux-Vekemans; A Chevalier; C A Bader; T B Drüeke; C Legendre; B Lacour; P Kamoun; H Kreis
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

7.  ACTH lowers serum lipids in steroid-treated hyperlipemic patients with kidney disease.

Authors:  A L Berg; P Nilsson-Ehle
Journal:  Kidney Int       Date:  1996-08       Impact factor: 10.612

8.  Lipid status after pancreas-kidney transplantation.

Authors:  J L Larsen; R J Stratta; C F Ozaki; R J Taylor; S A Miller; W C Duckworth
Journal:  Diabetes Care       Date:  1992-01       Impact factor: 19.112

9.  The effect of pravastatin on acute rejection after kidney transplantation--a pilot study.

Authors:  S Katznelson; A H Wilkinson; J A Kobashigawa; X M Wang; D Chia; M Ozawa; H P Zhong; M Hirata; A H Cohen; P I Teraski
Journal:  Transplantation       Date:  1996-05-27       Impact factor: 4.939

10.  Effects of systemic delivery of insulin on plasma lipids and lipoprotein concentrations in pancreas transplant recipients.

Authors:  H H Katz; T T Nguyen; J A Velosa; R P Robertson; R A Rizza
Journal:  Mayo Clin Proc       Date:  1994-03       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.